Modeling study supports an FDA-approved product over off-label amitriptyline ...

Fibromyalgia is a long-term chronic condition that causes widespread pain in the muscles and soft tissues throughout the body. The illness can affect people of all ages and has a major impact on ...

Duloxetine 120 mg offers the greatest economic value for treating moderate-to-severe fibromyalgia, followed by pregabalin 450 ...

Credit: Tonix Pharmaceuticals. Tonmya is a once-daily sublingual tablet of cyclobenzaprine HCI taken at bedtime for the treatment of fibromyalgia. Clinical trials have demonstrated that Tonmya reduces ...

In August 2025, the US Food and Drug Administration (FDA) approved Tonmya ® (cyclobenzaprine hydrochloride sublingual tablets; Tonix Pharmaceuticals) for the treatment of fibromyalgia in adults. Study ...

The FDA has approved cyclobenzaprine hydrochloride sublingual tablets (Tonmya, Tonix Pharmaceuticals), a first-in-class, nonopioid treatment for adults with fibromyalgia, a chronic pain syndrome that ...

Credit: Tonix Pharmaceuticals. The approval was supported by data from 3 double-blind, placebo-controlled trials that included a total of 1474 patients who met the 2016 ACR criteria for diagnosis of ...

LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the ...

CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp.

Children and adolescents affected by juvenile fibromyalgia show greater sensitivity to non-painful sensory stimuli, such as ...

Fibromyalgia pain can be widespread and often flares up throughout the day. But even at night, fibromyalgia symptoms won't quit, robbing you of precious sleep. Fibromyalgia is known for the chronic ...